This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kubbutat, M. H. G.
Right arrow Articles by Vousden, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kubbutat, M. H. G.
Right arrow Articles by Vousden, K. H.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, October 1998, p. 5690-5698, Vol. 18, No. 10
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Regulation of Mdm2-Directed Degradation by the C Terminus of p53

Michael H. G. Kubbutat, Robert L. Ludwig, Margaret Ashcroft, and Karen H. Vousden*

ABL-Basic Research Program, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201

Received 9 February 1998/Returned for modification 27 March 1998/Accepted 15 July 1998

The stability of the p53 tumor suppressor protein is regulated by interaction with Mdm2, the product of a p53-inducible gene. Mdm2-targeted degradation of p53 depends on the interaction between the two proteins and is mediated by the proteasome. We show here that in addition to the N-terminal Mdm2 binding domain, the C terminus of p53 participates in the ability of p53 to be degraded by Mdm2. In contrast, alterations in the central DNA binding domain of p53, which change the conformation of the p53 protein, do not abrogate the sensitivity of the protein to Mdm2-mediated degradation. The importance of the C-terminal oligomerization domain to Mdm2-targeted degradation of p53 is likely to reflect the importance of oligomerization of the full-length p53 protein for interaction with Mdm2, as previously shown in vitro. Interestingly, the extreme C-terminal region of p53, outside the oligomerization domain, was also shown to be necessary for efficient degradation, and deletion of this region stabilized the protein without abrogating its ability to bind to Mdm2. Mdm2-resistant p53 mutants were not further stabilized following DNA damage, supporting a role for Mdm2 as the principal regulator of p53 stability in cells. The extreme C terminus of the p53 protein has previously been shown to contain several regulatory elements, raising the possibility that either allosteric regulation of p53 by this domain or interaction between this region and a third protein plays a role in determining the sensitivity of p53 to Mdm2-directed degradation.

* Corresponding author. Mailing address: ABL Basic Research Program, NCI-FCRDC, Building 560, Room 22-96, P.O. Box B, Frederick, MD 21702-1201. Phone: (301) 846-1726. Fax: (301) 846-1666. E-mail: vousden{at}ncifcrf.gov.

Molecular and Cellular Biology, October 1998, p. 5690-5698, Vol. 18, No. 10
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Smeenk, L., van Heeringen, S. J., Koeppel, M., van Driel, M. A., Bartels, S. J. J., Akkers, R. C., Denissov, S., Stunnenberg, H. G., Lohrum, M. (2008). Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Res 36: 3639-3654 [Abstract] [Full Text]  
  • LaFevre-Bernt, M., Wu, S., Lin, X. (2008). Recombinant, refolded tetrameric p53 and gonadotropin-releasing hormone-p53 slow proliferation and induce apoptosis in p53-deficient cancer cells. Molecular Cancer Therapeutics 7: 1420-1429 [Abstract] [Full Text]  
  • Cuddihy, A. R., Jalali, F., Coackley, C., Bristow, R. G. (2008). WTp53 induction does not override MTp53 chemoresistance and radioresistance due to gain-of-function in lung cancer cells. Molecular Cancer Therapeutics 7: 980-992 [Abstract] [Full Text]  
  • Lukashchuk, N., Vousden, K. H. (2007). Ubiquitination and Degradation of Mutant p53. Mol. Cell. Biol. 27: 8284-8295 [Abstract] [Full Text]  
  • Giono, L. E., Manfredi, J. J. (2007). Mdm2 Is Required for Inhibition of Cdk2 Activity by p21, Thereby Contributing to p53-Dependent Cell Cycle Arrest. Mol. Cell. Biol. 27: 4166-4178 [Abstract] [Full Text]  
  • Kaustov, L., Lukin, J., Lemak, A., Duan, S., Ho, M., Doherty, R., Penn, L. Z., Arrowsmith, C. H. (2007). The Conserved CPH Domains of Cul7 and PARC Are Protein-Protein Interaction Modules That Bind the Tetramerization Domain of p53. J. Biol. Chem. 282: 11300-11307 [Abstract] [Full Text]  
  • Kulikov, R., Winter, M., Blattner, C. (2006). Binding of p53 to the Central Domain of Mdm2 Is Regulated by Phosphorylation. J. Biol. Chem. 281: 28575-28583 [Abstract] [Full Text]  
  • Yang, X., Fraser, M., Moll, U. M., Basak, A., Tsang, B. K. (2006). Akt-Mediated Cisplatin Resistance in Ovarian Cancer: Modulation of p53 Action on Caspase-Dependent Mitochondrial Death Pathway.. Cancer Res. 66: 3126-3136 [Abstract] [Full Text]  
  • Tang, Y., Eng, C. (2006). PTEN Autoregulates Its Expression by Stabilization of p53 in a Phosphatase-Independent Manner. Cancer Res. 66: 736-742 [Abstract] [Full Text]  
  • Wong, H. K., Fricker, M., Wyttenbach, A., Villunger, A., Michalak, E. M., Strasser, A., Tolkovsky, A. M. (2005). Mutually Exclusive Subsets of BH3-Only Proteins Are Activated by the p53 and c-Jun N-Terminal Kinase/c-Jun Signaling Pathways during Cortical Neuron Apoptosis Induced by Arsenite. Mol. Cell. Biol. 25: 8732-8747 [Abstract] [Full Text]  
  • Feng, L., Lin, T., Uranishi, H., Gu, W., Xu, Y. (2005). Functional Analysis of the Roles of Posttranslational Modifications at the p53 C Terminus in Regulating p53 Stability and Activity. Mol. Cell. Biol. 25: 5389-5395 [Abstract] [Full Text]  
  • Del Carratore, R., Petrucci, A., Simili, M., Fronza, G., Galli, A. (2004). Involvement of human p53 in induced intrachromosomal recombination in Saccharomyces cerevisiae. Mutagenesis 19: 333-339 [Abstract] [Full Text]  
  • Chavez-Reyes, A., Parant, J. M., Amelse, L. L., de Oca Luna, R. M., Korsmeyer, S. J., Lozano, G. (2003). Switching Mechanisms of Cell Death in mdm2- and mdm4-null Mice by Deletion of p53 Downstream Targets. Cancer Res. 63: 8664-8669 [Abstract] [Full Text]  
  • Asher, G., Lotem, J., Tsvetkov, P., Reiss, V., Sachs, L., Shaul, Y. (2003). p53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1. Proc. Natl. Acad. Sci. USA 100: 15065-15070 [Abstract] [Full Text]  
  • Moll, U. M., Petrenko, O. (2003). The MDM2-p53 Interaction. Mol Cancer Res 1: 1001-1008 [Abstract] [Full Text]  
  • Anderson, K., Potter, A., Baban, D., Davies, K. E. (2003). Protein expression changes in spinal muscular atrophy revealed with a novel antibody array technology. Brain 126: 2052-2064 [Abstract] [Full Text]  
  • Bartl, S., Ban, J., Weninger, H., Jug, G., Kovar, H. (2003). A small nuclear RNA, hdm365, is the major processing product of the human mdm2 gene. Nucleic Acids Res 31: 1136-1147 [Abstract] [Full Text]  
  • Lohrum, M. A. E., Woods, D. B., Ludwig, R. L., Balint, E., Vousden, K. H. (2001). C-Terminal Ubiquitination of p53 Contributes to Nuclear Export. Mol. Cell. Biol. 21: 8521-8532 [Abstract] [Full Text]  
  • Peng, Y.-C., Kuo, F., Breiding, D. E., Wang, Y.-F., Mansur, C. P., Androphy, E. J. (2001). AMF1 (GPS2) Modulates p53 Transactivation. Mol. Cell. Biol. 21: 5913-5924 [Abstract] [Full Text]  
  • Bellanger, S., Demeret, C., Goyat, S., Thierry, F. (2001). Stability of the Human Papillomavirus Type 18 E2 Protein Is Regulated by a Proteasome Degradation Pathway through Its Amino-Terminal Transactivation Domain. J. Virol. 75: 7244-7251 [Abstract] [Full Text]  
  • Bai, L., Merchant, J. L. (2001). ZBP-89 Promotes Growth Arrest through Stabilization of p53. Mol. Cell. Biol. 21: 4670-4683 [Abstract] [Full Text]  
  • Irwin, M. S., Kaelin, W. G. (2001). p53 Family Update: p73 and p63 Develop Their Own Identities. Cell Growth Differ. 12: 337-349 [Full Text]  
  • Almog, N., Milyavsky, M., Stambolsky, P., Falcovitz, A., Goldfinger, N., Rotter, V. (2001). The role of the C' terminus of murine p53 in the p53/mdm-2 regulatory loop. Carcinogenesis 22: 779-785 [Abstract] [Full Text]  
  • Wang, X. Q., Ongkeko, W. M., Lau, A. W. S., Leung, K. M., Poon, R. Y. C. (2001). A Possible Role of p73 on the Modulation of p53 Level through MDM2. Cancer Res. 61: 1598-1603 [Abstract] [Full Text]  
  • Nakamura, S., Roth, J. A., Mukhopadhyay, T. (2000). Multiple Lysine Mutations in the C-Terminal Domain of p53 Interfere with MDM2-Dependent Protein Degradation and Ubiquitination. Mol. Cell. Biol. 20: 9391-9398 [Abstract] [Full Text]  
  • Rodriguez, M. S., Desterro, J. M. P., Lain, S., Lane, D. P., Hay, R. T. (2000). Multiple C-Terminal Lysine Residues Target p53 for Ubiquitin-Proteasome-Mediated Degradation. Mol. Cell. Biol. 20: 8458-8467 [Abstract] [Full Text]  
  • Lin, J., Jin, X., Page, C., Sondak, V. K., Jiang, G., Reynolds, R. K. (2000). A Modified p53 Overcomes mdm2-mediated Oncogenic Transformation: A Potential Cancer Therapeutic Agent. Cancer Res. 60: 5895-5901 [Abstract] [Full Text]  
  • Muller, S., Berger, M., Lehembre, F., Seeler, J.-S., Haupt, Y., Dejean, A. (2000). c-Jun and p53 Activity Is Modulated by SUMO-1 Modification. J. Biol. Chem. 275: 13321-13329 [Abstract] [Full Text]  
  • Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., Weissman, A. M. (2000). Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53. J. Biol. Chem. 275: 8945-8951 [Abstract] [Full Text]  
  • Feng, G. H., Lih, C.-J., Cohen, S. N. (2000). TSG101 Protein Steady-State Level Is Regulated Posttranslationally by an Evolutionarily Conserved COOH-Terminal Sequence. Cancer Res. 60: 1736-1741 [Abstract] [Full Text]  
  • Gu, J., Chen, D., Rosenblum, J., Rubin, R. M., Yuan, Z.-M. (2000). Identification of a Sequence Element from p53 That Signals for Mdm2-Targeted Degradation. Mol. Cell. Biol. 20: 1243-1253 [Abstract] [Full Text]  
  • Scotto, C., Delphin, C., Deloulme, J. C., Baudier, J. (1999). Concerted Regulation of Wild-Type p53 Nuclear Accumulation and Activation by S100B and Calcium-Dependent Protein Kinase C. Mol. Cell. Biol. 19: 7168-7180 [Abstract] [Full Text]  
  • Zaika, A., Marchenko, N., Moll, U. M. (1999). Cytoplasmically "Sequestered" Wild Type p53 Protein Is Resistant to Mdm2-mediated Degradation. J. Biol. Chem. 274: 27474-27480 [Abstract] [Full Text]  
  • Osman, I., Drobnjak, M., Fazzari, M., Ferrara, J., Scher, H. I., Cordon-Cardo, C. (1999). Inactivation of the p53 Pathway in Prostate Cancer: Impact on Tumor Progression. Clin. Cancer Res. 5: 2082-2088 [Abstract] [Full Text]  
  • Maki, C. G. (1999). Oligomerization Is Required for p53 to be Efficiently Ubiquitinated by MDM2. J. Biol. Chem. 274: 16531-16535 [Abstract] [Full Text]  
  • Zeng, X., Chen, L., Jost, C. A., Maya, R., Keller, D., Wang, X., Kaelin, W. G. Jr., Oren, M., Chen, J., Lu, H. (1999). MDM2 Suppresses p73 Function without Promoting p73 Degradation. Mol. Cell. Biol. 19: 3257-3266 [Abstract] [Full Text]  
  • Ashcroft, M., Kubbutat, M. H. G., Vousden, K. H. (1999). Regulation of p53 Function and Stability by Phosphorylation. Mol. Cell. Biol. 19: 1751-1758 [Abstract] [Full Text]  
  • Kubbutat, M. H. G., Ludwig, R. L., Levine, A. J., Vousden, K. H. (1999). Analysis of the Degradation Function of Mdm2. Cell Growth Differ. 10: 87-92 [Abstract] [Full Text]  
  • Yap, D. B. S., Hsieh, J.-K., Lu, X. (2000). Mdm2 Inhibits the Apoptotic Function of p53 Mainly by Targeting It for Degradation. J. Biol. Chem. 275: 37296-37302 [Abstract] [Full Text]  
  • Zhu, J., Zhang, S., Jiang, J., Chen, X. (2000). Definition of the p53 Functional Domains Necessary for Inducing Apoptosis. J. Biol. Chem. 275: 39927-39934 [Abstract] [Full Text]  
  • Lai, Z., Ferry, K. V., Diamond, M. A., Wee, K. E., Kim, Y. B., Ma, J., Yang, T., Benfield, P. A., Copeland, R. A., Auger, K. R. (2001). Human mdm2 Mediates Multiple Mono-ubiquitination of p53 by a Mechanism Requiring Enzyme Isomerization. J. Biol. Chem. 276: 31357-31367 [Abstract] [Full Text]  
  • Chernov, M. V., Bean, L. J. H., Lerner, N., Stark, G. R. (2001). Regulation of Ubiquitination and Degradation of p53 in Unstressed Cells through C-terminal Phosphorylation. J. Biol. Chem. 276: 31819-31824 [Abstract] [Full Text]  
  • Inoue, T., Geyer, R. K., Howard, D., Yu, Z. K., Maki, C. G. (2001). MDM2 Can Promote the Ubiquitination, Nuclear Export, and Degradation of p53 in the Absence of Direct Binding. J. Biol. Chem. 276: 45255-45260 [Abstract] [Full Text]  
  • Young, P. J., Day, P. M., Zhou, J., Androphy, E. J., Morris, G. E., Lorson, C. L. (2002). A Direct Interaction between the Survival Motor Neuron Protein and p53 and Its Relationship to Spinal Muscular Atrophy. J. Biol. Chem. 277: 2852-2859 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»